Search Records

Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not helped. Clozapine was developed in the 1960s. In 1975, clozapine was removed from the Canadian market because of reports of life-threatening infections and deaths linked...

Requirements for manufacturers and importers for collecting medical device safety information and provide notification to Health Canada. A monitoring process should be in place to ensure compliance.

This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to 61.6 of the Medical Devices Regulations. Two new requirements in the Regulations were added to ensure the continued monitoring of benefits and risks after a product is...

This funding is designed to protect Canadians from vaccine preventable disease by supporting our health partners in three priority areas: Build capacity of Health Care Providers as vaccinators and vaccination promoters; Support Community-based COVID-19 Education, Promotion and Outreach; and Build...

Instructions of how to stop illegal marketing of drugs and devices.

The Infectious Disease and Climate Change Fund (IDCCF) addresses the impact of climate change on human health in Canada by: increasing capacity, enabling Canadians and communities and improving adaptability and resiliency.

Individual surveillance systems have various public health goals and policy objectives. In recent years, the scope of, and our reliance on, surveillance systems have grown significantly in all parts of the world because of globalization and threats of multi-drug resistant bacteria, bioterrorism...

The national incidence of foodborne pathogens is actively collected and reported by the National Enteric Surveillance Program (NESP). The NESP has been in operation since April 1997 and is designed to provide timely analysis and reporting of laboratory confirmed enteric disease cases in Canada.

The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use and antimicrobial resistance in selected bacterial organisms from human, animal and food sources across Canada. The program is based on several representative and...

This 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report provides a detailed assessment of antimicrobial resistance (AMR) in Canada. This report also provides recent information on the amount of antimicrobials used in humans and animals, as antimicrobial use (AMU) is one of...